Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...
Dec 11, 2017
1
9